• Thursday, September 18, 2014
  • 11:30 AM–12:20 PM
  • Science Building Lecture Hall 010

More information

Veliparib (ABT-888): A PARP Inhibitor for the Treatment of Cancer presented by Dr. Tom Penning, Abbvie Pharmaceutical